Drug Candidate Reduced Brain Inflammation and Protected Against Cognitive Decline in Alzheimer's Mouse Model

3,6'-dithiopomalidomide (DP), an anti-inflammatory drug candidate, protected mouse models of Alzheimer's disease against cognitive decline by reducing neuroinflammation.